News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Enzymotec Files Registration Statement For Proposed Secondary Offering


2/13/2014 9:33:09 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MIGDAL HA'EMEQ, Israel, Feb. 13, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company") today announced that it has filed a registration statement on Form F-1 with the Securities and Exchange Commission for a proposed secondary public offering of 4,000,000 of its ordinary shares. The underwriters will have a 30-day option from the date of the offering to purchase up to an additional 600,000 ordinary shares. All of the shares will be offered by the Company's shareholders. The Company will not receive any proceeds from the sale of these shares.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
Enzymotec
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES